Indacaterol/glycopyrrolate Significantly Improves Health Status And Dyspnea In Different Subgroups Of Patients With Moderate-To-Severe COPD: Pooled Analysis Of Flight1 And Flight2 Studies

被引:0
|
作者
Mahler, D. A. [1 ]
Donohue, J. F. [2 ]
Fucile, S. [3 ]
Yadao, A. [3 ]
Maitra, S. [4 ]
Taylor, A. Fowler [3 ]
Fogel, R. [3 ]
Patalano, F. [5 ]
Banerji, D. [3 ]
机构
[1] Geisel Sch Med Dartmouth, Lebanon, NH USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Novartis Healthcare Pvt Ltd, Hyderabad, Andhra Pradesh, India
[5] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5467
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Qva149 Provides Superior Improvement In Lung Function Versus Its Monocomponents In Patients With Moderate-To-Severe COPD: The Flight2 Study
    Kerwin, E. M.
    Ayers, T.
    FowlerTaylor, A.
    Larbig, M.
    Thach, C.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [42] Effect of Metabolic Syndrome Status on Lung Function and Patient- reported Outcomes in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Indacaterol/Glycopyrrolate: Co-morbidity Analysis of the Phase 3 FLIGHT1 and 2 Studies
    Carlin, Brian
    Ferguson, Gary T.
    Sanjar, Shahin
    Sharma, Sanjay
    Ozol-Godfrey, Ayca
    Goodin, Thomas
    CIRCULATION, 2018, 138
  • [43] Effect Of Glycopyrrolate On Lung Function, Health Status And Dyspnea In Age Subgroups: A Pooled Analysis From The Gem1 And Gem2 Studies
    Mahler, D. A.
    Kerwin, E.
    Gifford, A. H.
    Yadao, A.
    D'Andrea, P.
    Uddin, A.
    Bray, B. Franke
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [44] Glycopyrronium Demonstrates Significant Improvements in Lung Function in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1 and GEM2 Studies
    Kerwin, Edward
    Spangenthal, Selwyn
    Miller, S. David
    D'Andrea, Peter
    Henley, Michelle
    Eckert, Joerg H.
    Patalano, Francesco
    CHEST, 2015, 148 (04)
  • [45] Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies
    Gordon, K. B.
    Blauvelt, A.
    Foley, P.
    Song, M.
    Wasfi, Y.
    Randazzo, B.
    Shen, Y. K.
    You, Y.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : 132 - 139
  • [46] Glycopyrronium Twice Daily Improves Lung Function And Health Status And Is Well Tolerated In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem2 Study
    Kerwin, E. M.
    Siler, T. M.
    Korenblat, P. E.
    White, A. C.
    Eckert, J. H.
    Cha, E.
    Mota, F.
    Andrea, P. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [47] Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies
    Reich, K.
    Papp, K. A.
    Armstrong, A. W.
    Wasfi, Y.
    Li, S.
    Shen, Y. K.
    Randazzo, B.
    Song, M.
    Kimball, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 1039 - 1049
  • [48] Nemolizumab monotherapy improves itch, sleep disturbance, and skin lesions in patients with moderate-to-severe prurigo nodularis: Pooled analyses from OLYMPIA 1 and OLYMPIA 2 phase 3 studies
    Yosipovitch, Gil
    Staender, Sonja
    Metz, Martin
    Pink, Andrew E.
    Silverberg, Jonathan, I
    Sofen, Howard
    Ahmed, Faiz
    Noda, Aliene
    Lopez, Zarif K. Jabbar
    Piketty, Christophe
    Kwatra, Shawn G.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 47 - 48
  • [49] Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies
    Donald P. Tashkin
    Thomas Goodin
    Alyssa Bowling
    Barry Price
    Ayca Ozol-Godfrey
    Sanjay Sharma
    Shahin Sanjar
    Respiratory Research, 20
  • [50] Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies
    Tashkin, Donald P.
    Goodin, Thomas
    Bowling, Alyssa
    Price, Barry
    Ozol-Godfrey, Ayca
    Sharma, Sanjay
    Sanjar, Shahin
    RESPIRATORY RESEARCH, 2019, 20 (1):